Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial

« Previous Next »Journal of Dermatological Science
Volume 59, Issue 1 , Pages 40-49, July 2010

Hideshi Torii
- Division of Dermatology, Social Insurance Central General Hospital, 3-22-1 Hyakunincho, Shinjyuku, Tokyo 169-0073, Japan
- Corresponding author. Tel.: +81 3 3364 0251; fax: +81 3 3364 5663.
Hidemi Nakagawa
- Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan
the Japanese Infliximab Study investigators
- Investigators for the Japanese Infliximab Study include: H Iizuka, Hokkaido; S Aoyagi, Hokkaido; R Okuyama, Miyagi; M Ohtsuki, Tochigi; M Abe, Gunma; K Takamori, S Matsuba, Chiba; T Terui, Tokyo; A Igarashi, Tokyo; M Kawashima, Tokyo; M Amagai, Y Takae, Tokyo; H Eto, Tokyo; T Etoh, Tokyo; S Ikeda, Tokyo; M Komine, H Saeki, Tokyo; K Hayakawa, Tokyo; A Kitami, H Watanabe, Tokyo; K Takehara, Ishikawa; S Shimada, Yamanashi; Y Kitajima, Gifu; M Takigawa, Shizuoka; A Morita, Aichi; K Yamanaka, Mie; K Takahashi, Kyoto; M Tarutani, M Tani, Osaka; Y Kubota, Kagawa; J Nakayama, Fukuoka; H Ihn, Kumamoto.